[What is reliable in the therapy of hematologic diseases? I. Hemoblastosis and malignant lymphoproliferative diseases].
作者信息
Havemann K, Schmidt M, Malchow H, Sodomann C P
出版信息
Internist (Berl). 1970 Dec;11(12):441-9.
PMID:4993105
Abstract
摘要
相似文献
1
[What is reliable in the therapy of hematologic diseases? I. Hemoblastosis and malignant lymphoproliferative diseases].
Internist (Berl). 1970 Dec;11(12):441-9.
2
[New viewpoints for indication for radiologic treatment in leukoses and retikuloses].
Strahlentherapie. 1968 Jun;135(6):641-55.
3
[Results of cytostatic therapy of malignant hemoblastoses].
Wien Z Inn Med. 1966 Jan;47(1):1-16.
4
[Rehabilitation and cure of patients with hemoblastoses].
Dtsch Med J. 1968 Mar 5;19(5):161-3.
5
[Drug therapy in hemoblastosis].
Folia Clin Int (Barc). 1968 Jun;18(6):365-8.
6
[Clinical research on the antipyretic effects of indomethacin in systemic hemopathies].
Minerva Med. 1970 Oct 13;61(82):4532-41.
7
[Personal experience on the chemotherapy of leukemias and hematosarcomas].
Acta Genet Med Gemellol (Roma). 1968 Jan;17(1):245-54.
8
[Therapy of hemoblastosis. I. Elements of cytostatic and symptomatic therapy].
G Clin Med. 1966 Aug;47(8):732-68.
9
[Therapeutic progress and iatrogenic problems in malignant hemopathies].
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna. 1977 Jul-Aug;29(4):343-9.
10
Trenimon treatment in chronic hemoblastoses.
Acta Genet Med Gemellol (Roma). 1968 Jan;17(1):145-52. doi: 10.1017/s1120962300026354.
Zotero 插件